Announcements

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Infectious Agents and Cancer”, which are listed below:

1. “An Assessment of Young Adults’ Awareness and Knowledge Related to the Human Papillomavirus (HPV), Oropharyngeal Cancer, and the HPV Vaccine”
by Eric N. Davis and Philip C. Doyle
Cancers 2025, 17(3), 344; https://doi.org/10.3390/cancers17030344
Available online: https://www.mdpi.com/2072-6694/17/3/344

2. “Involvement of Oral Microbiome in the Development of Oral Malignancy”
by Hitoshi Isono, Shintaro Nakajima, Satoshi Watanabe, Aya K. Takeda, Haruka Yoshii, Ami Shimoda, Hisao Yagishita, Kenji Mitsudo and Mitomu Kioi
Cancers 2025, 17(4), 632; https://doi.org/10.3390/cancers17040632
Available online: https://www.mdpi.com/2072-6694/17/4/632

3. “Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development”
by Rancés Blanco and Juan P. Muñoz
Cancers 2025, 17(4), 582; https://doi.org/10.3390/cancers17040582
Available online: https://www.mdpi.com/2072-6694/17/4/582

4. “Epstein–Barr Infection, Hodgkin’s Lymphoma, and the Immune System: Insights into the Molecular Mechanisms Facilitating Immune Evasion”
by Eleni Tsotridou and Emmanouel Hatzipantelis
Cancers 2025, 17(9), 1481; https://doi.org/10.3390/cancers17091481
Available online: https://www.mdpi.com/2072-6694/17/9/1481

5. “Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications”
by Jirapat Wonglhow, Jarukit Tantipisit, Panu Wetwittayakhlang, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Kanet Kanjanapradit, Phatcharaporn Thongwatchara and Arunee Dechaphunkul
Cancers 2025, 17(9), 1492; https://doi.org/10.3390/cancers17091492
Available online: https://www.mdpi.com/2072-6694/17/9/1492

6. “Ozone–Oxygen Therapy to Prevent HPV-Related Cancers of the Lower Gynecological Tract in Infected Patients: The Rationale for Further Developments”
by Luca Roncati
Cancers 2025, 17(3), 543; https://doi.org/10.3390/cancers17030543
Available online: https://www.mdpi.com/2072-6694/17/3/543

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Tumor Microenvironment”, which are listed below:

1. “Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma”
by Sulin Wu, Namrata Anand, Zhoubo Guo, Mingyang Li, Marcos Santiago Figueroa, Lauren Jung, Sarah Kelly and Joseph W. Franses
Cancers 2025, 17(11), 1860; https://doi.org/10.3390/cancers17111860
Available online: https://www.mdpi.com/2072-6694/17/11/1860

2. “Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways”
by Mario Seres, Katarina Spacayova, Zdena Sulova, Jana Spaldova, Albert Breier and Lucia Pavlikova
Cancers 2025, 17(2), 248; https://doi.org/10.3390/cancers17020248
Available online: https://www.mdpi.com/2072-6694/17/2/248

3. “A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches”
by Mina Iskandar, Miguel Xiao Barbero, Muhamed Jaber, Roy Chen, Romulo Gomez-Guevara, Edwin Cruz and Sandy Westerheide
Cancers 2025, 17(2), 257; https://doi.org/10.3390/cancers17020257
Available online: https://www.mdpi.com/2072-6694/17/2/257

4. “The Complexity of Malignant Glioma Treatment”
by Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, Fabio Scirocchi, Sophie Veldhuijzen van Zanten, Matthias Eyrich, Veronica Biassoni, Esther Hulleman, Michael Karremann, Wilfried Stücker et al.
Cancers 2025, 17(5), 879; https://doi.org/10.3390/cancers17050879
Available online: https://www.mdpi.com/2072-6694/17/5/879

5. “Optimizing Cancer Treatment Through Gut Microbiome Modulation”
by Kyuri Kim, Mingyu Lee, Yoojin Shin, Yoonji Lee and Tae-Jung Kim
Cancers 2025, 17(7), 1252; https://doi.org/10.3390/cancers17071252
Available online: https://www.mdpi.com/2072-6694/17/7/1252

6. “Metabolic Signaling in the Tumor Microenvironment”
by Ryan Clay, Kunyang Li and Lingtao Jin
Cancers 2025, 17(1), 155; https://doi.org/10.3390/cancers17010155
Available online: https://www.mdpi.com/2072-6694/17/1/155

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Immunology and Immunotherapy”, which are listed below:

1. “The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities”
by Ravi Medikonda, Matthew Abikenari, Ethan Schonfeld and Michael Lim
Cancers 2025, 17(11), 1881; https://doi.org/10.3390/cancers17111881
Available online: https://www.mdpi.com/2072-6694/17/11/1881

2. “Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer”
by Zhan Xu, Zijian Zhou, Jong Bum Son, Haonan Feng, Beatriz E. Adrada, Tanya W. Moseley, Rosalind P. Candelaria, Mary S. Guirguis, Miral M. Patel, Gary J. Whitman et al.
Cancers 2025, 17(6), 966; https://doi.org/10.3390/cancers17060966
Available online: https://www.mdpi.com/2072-6694/17/6/966

3. “Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses”
by Jacopo Canzian, Fabio Conforti, Flavia Jacobs, Chiara Benvenuti, Mariangela Gaudio, Riccardo Gerosa, Rita De Sanctis and Alberto Zambelli
Cancers 2025, 17(7), 1054; https://doi.org/10.3390/cancers17071054
Available online: https://www.mdpi.com/2072-6694/17/7/1054

4. “Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy”
by Thomas Eckert, M. S. Zobaer, Jessie Boulos, Angela Alexander-Bryant, Tiffany G. Baker, Charlotte Rivers, Arabinda Das, William A. Vandergrift, Jaime Martinez, Alicia Zukas et al.
Cancers 2025, 17(3), 462; https://doi.org/10.3390/cancers17030462
Available online: https://www.mdpi.com/2072-6694/17/3/462

5. “Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma”
by Vlad-Mihai Voiculescu, Alina-Ioana Popescu and Mariana Costache
Cancers 2025, 17(11), 1769; https://doi.org/10.3390/cancers17111769
Available online: https://www.mdpi.com/2072-6694/17/11/1769

6. “Single-Agent and Associated Therapies with Monoclonal Antibodies: What About Follicular Lymphoma?”
by Gabriella Cancemi, Chiara Campo, Santino Caserta, Iolanda Rizzotti and Donato Mannina
Cancers 2025, 17(10), 1602; https://doi.org/10.3390/cancers17101602
Available online: https://www.mdpi.com/2072-6694/17/10/1602

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Pathophysiology”, which are listed below:

1. “From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer”
by Thulo Molefi, Lloyd Mabonga, Rodney Hull, Motshedisi Sebitloane and Zodwa Dlamini
Cancers 2025, 17(2), 320; https://doi.org/10.3390/cancers17020320
Available online: https://www.mdpi.com/2072-6694/17/2/320

2. “Translational Advances in Oncogene and Tumor-Suppressor Gene Research”
by Radoslav Stojchevski, Edward Agus Sutanto, Rinni Sutanto, Nikola Hadzi-Petrushev, Mitko Mladenov, Sajal Raj Singh, Jitendra Kumar Sinha, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Krishna Kumar Singh et al.
Cancers 2025, 17(6), 1008; https://doi.org/10.3390/cancers17061008
Available online: https://www.mdpi.com/2072-6694/17/6/1008

3. “The Gut–Endometrium Axis: Exploring the Role of Microbiome in the Pathogenesis and Treatment of Endometrial Cancer—A Narrative Review”
by Beibei Zhang, Nur Fatin Nabilah Mohd Sahardi, Wen Di, Xiaoran Long and Mohamad Nasir Shafiee
Cancers 2025, 17(6), 1044; https://doi.org/10.3390/cancers17061044
Available online: https://www.mdpi.com/2072-6694/17/6/1044

4. “Sexual-Sparing Radical Cystectomy in the Robot-Assisted Era: A Review on Functional and Oncological Outcomes”
by Carlo Introini, Manfredi Bruno Sequi, Marco Ennas, Andrea Benelli, Giovanni Guano, Antonio Luigi Pastore and Antonio Carbone
Cancers 2025, 17(1), 110; https://doi.org/10.3390/cancers17010110
Available online: https://www.mdpi.com/2072-6694/17/1/110

5. “Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management”
by Huina Zhang and Yan Peng
Cancers 2025, 17(3), 417; https://doi.org/10.3390/cancers17030417
Available online: https://www.mdpi.com/2072-6694/17/3/417

6. “Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations”
by Ersin Karatayli, Shifana C. Sadiq,örn M. Schattenberg, Stephan Grabbe, Bernhard Biersack and Leonard Kaps
Cancers 2025, 17(3), 484; https://doi.org/10.3390/cancers17030484
Available online: https://www.mdpi.com/2072-6694/17/3/484

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Clinical Research of Cancer”, which are listed below:

1. “Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)”
by  Syeda A. Mina,  Mohamed Shanshal,  Konstantinos Leventakos and Kaushal Parikh
Cancers 2025, 17(3), 353; https://doi.org/10.3390/cancers17030353
Available online: https://www.mdpi.com/2072-6694/17/3/353

2. “Robotic-Assisted Colon Cancer Surgery: Faster Recovery and Less Pain Compared to Laparoscopy in a Retrospective Propensity-Matched Study”
by Chun-Yu Lin, Yi-Chun Liu, Chou-Chen Chen, Ming-Cheng Chen, Teng-Yi Chiu, Yi-Lin Huang, Shih-Wei Chiang, Chang-Lin Lin, Ying-Jing Chen, Chen-Yan Lin et al.
Cancers 2025, 17(2), 243; https://doi.org/10.3390/cancers17020243
Available online: https://www.mdpi.com/2072-6694/17/2/243

3. “Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib”
by Takeshi Terashima, Hidenori Kido, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Tadashi Toyama, Noriho Iida, Shinya Yamada et al.
Cancers 2025, 17(2), 278; https://doi.org/10.3390/cancers17020278
Available online: https://www.mdpi.com/2072-6694/17/2/278

4. “Gas Plasma Technology and Immunogenic Cell Death: Implications for Chordoma Treatment”
by Sander Bekeschus, Karl Roessler, Oliver Kepp and Eric Freund
Cancers 2025, 17(4), 681; https://doi.org/10.3390/cancers17040681
Available online: https://www.mdpi.com/2072-6694/17/4/681

5. “Impact of Class III Obesity (Morbid Obesity) on the Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Radical Prostatectomy“
by Abdel Rahman Jaber, Shady Saikali, Marcio Covas Moschovas, Ahmed Gamal, Ela Patel, Marco Sandri, Travis Rogers and Vipul Patel
Cancers 2025, 17(4), 709; https://doi.org/10.3390/cancers17040709
Available online: https://www.mdpi.com/2072-6694/17/4/709

6. “A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for Treatment”
by Kangwen Xiao, Kuangying Yang and Angela C. Hirbe
Cancers 2025, 17(2), 180; https://doi.org/10.3390/cancers17020180
Available online: https://www.mdpi.com/2072-6694/17/2/180

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Methods and Technologies Development”, which are listed below:

1. “Exploring Artificial Intelligence Biases in Predictive Models for Cancer Diagnosis”
by Aref Smiley, C. Mahony Reategui-Rivera, David Villarreal-Zegarra, Stefan Escobar-Agreda and Joseph Finkelstein
Cancers 2025, 17(3), 407; https://doi.org/10.3390/cancers17030407
Available online: https://www.mdpi.com/2072-6694/17/3/407

2. “Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions”
by Maximilian Deußing, Lisa Buttgereit, Michaela Maurer, Alisa Swarlik, Lara Stärr, Andreas Ohlmann, Katrin Kerl-French, Michael Flaig, Elke C. Sattler, Lars E. French et al.
Cancers 2025, 17(1), 151; https://doi.org/10.3390/cancers17010151
Available online: https://www.mdpi.com/2072-6694/17/1/151

3. “Robotic Surgery in Severely Obese Frail Patients for the Treatment of Atypical Endometrial Hyperplasia and Endometrial Cancer: A Propensity-Match Analysis at an ESGO-Accredited Center”
by Martina Arcieri, Federico Paparcura, Cristina Giorgiutti, Cristina Taliento, Giorgio Bogani, Lorenza Driul, Pantaleo Greco, Alfredo Ercoli, Vito Chiantera, Francesco Fanfani et al.
Cancers 2025, 17(3), 482; https://doi.org/10.3390/cancers17030482
Available online: https://www.mdpi.com/2072-6694/17/3/482

4. “Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma”
by Giuseppe Stefano Netti, Federica De Luca, Valentina Camporeale, Javeria Khalid, Giorgia Leccese, Dario Troise, Francesca Sanguedolce, Giovanni Stallone and Elena Ranieri
Cancers 2025, 17(9), 1442; https://doi.org/10.3390/cancers17091442
Available online: https://www.mdpi.com/2072-6694/17/9/1442

5. “The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS)”
by Marco Parillo and Carlo Augusto Mallio
Cancers 2025, 17(2), 275; https://www.mdpi.com/2072-6694/17/2/275
Available online: https://www.mdpi.com/2072-6694/17/2/275

6. “A Comparison of the Efficacy and Safety of US-, CT-, and MR-Guided Radiofrequency and Microwave Ablation for HCC: A Systematic Review and Network Meta-Analysis”
by Hao Li, Thomas J. Vogl, Kuei-An Chen and Hamzah Adwan
Cancers 2025, 17(3), 409; https://doi.org/10.3390/cancers17030409
Available online: https://www.mdpi.com/2072-6694/17/3/409

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Systematic Review or Meta-Analysis in Cancer Research”, which are listed below:

1. “The Efficacy of Music Intervention in Patients with Cancer Receiving Radiation Therapy: A Systematic Review and Meta-Analysis”
by Alisha E. Sharma, Stephanie Chan, Adam S. Komorowski, Xingshan Cao, Yizhuo Gao, Kushal Kshatri, Kairavi Desai, Markus Kuksis, Michael Rosen, Anjali Sachdeva et al.
Cancers 2025, 17(8), 1357; https://doi.org/10.3390/cancers17081357
Available online: https://www.mdpi.com/2072-6694/17/8/1357

2. “The Role of Chronic Inflammation in Pediatric Cancer”
by Hsiao-Hsuan Chen, Chia-Hsuan Lai, Yu-Jen Hou and Liang-Tseng Kuo
Cancers 2025, 17(4), 691; https://doi.org/10.3390/cancers17040691
Available online: https://doi.org/10.3390/cancers17040691

3. “Delay in Diagnosis and Treatment of Bone Sarcoma—Systematic Review”
by Dawid Ciechanowicz, Daniel Kotrych, Krzysztof Starszak, Piotr Prowans, Sławomir Zacha, Adam Kamiński, Adam Brodecki and Katarzyna Kotrych
Cancers 2025, 17(6), 981;chttps://doi.org/10.3390/cancers17060981
Available online: https://www.mdpi.com/2072-6694/17/6/981

4. “Evaluation of Urinary miRNA in Renal Cell Carcinoma: A Systematic Review”
by Giovanni Cochetti, Liliana Guadagni, Alessio Paladini, Miriam Russo, Raffaele La Mura, Andrea Vitale, Eleonora Saqer, Paolo Mangione, Riccardo Esposito, Manfredi Gioè et al.
Cancers 2025, 17(8), 1336; https://doi.org/10.3390/cancers17081336
Available online: https://doi.org/10.3390/cancers17081336

5. “Comparison of Weekly and Triweekly Cisplatin Regimens in the Treatment of Head and Neck Cancer: A Systematic Review and Meta-Analysis”
by Sylwester M. Kloska and Anna Kloska
Cancers 2025, 17(9), 1444; https://doi.org/10.3390/cancers17091444
Available online: https://doi.org/10.3390/cancers17091444

6. “Applications of Artificial Intelligence for Metastatic Gastrointestinal Cancer: A Systematic Literature Review”
by Amin Naemi, Ashkan Tashk, Amir Sorayaie Azar, Tahereh Samimi, Ghanbar Tavassoli, Anita Bagherzadeh Mohasefi, Elaheh Nasiri Khanshan, Mehrdad Heshmat Najafabad, Vafa Tarighi,
Uffe Kock Wiil et al.
Cancers 2025, 17(3), 558; https://doi.org/10.3390/cancers17030558
Available online: https://doi.org/10.3390/cancers17030558

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Biomarkers”, which are listed below:

1. “Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies”
by Eduarda Carvalho, Sule Canberk, Fernando Schmitt and Nuno Vale
Cancers 2025, 17(7), 1102; https://doi.org/10.3390/cancers17071102
Available online: https://www.mdpi.com/2072-6694/17/7/1102

2. “Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)”
by Hannah L. Steinberg-Vorhoff, Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim and Johannes M. Ludwig
Cancers 2025, 17(4), 647; https://doi.org/10.3390/cancers17040647
Available online: https://www.mdpi.com/2072-6694/17/4/647

3. “KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma”
by Paulina Antosik, Justyna Durślewic, Marta Smolińska-Świtała, Jonasz Podemski, Edyta Podemska, Izabela Neska-Długosz, Jakub Jóźwicki and Dariusz Grzanka
Cancers 2025, 17(5), 804; https://doi.org/10.3390/cancers17050804
Available online: https://www.mdpi.com/2072-6694/17/5/804

4.“Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities”
by Hina Amer, Katie L. Flanagan, Nirmala C. Kampan, Catherine Itsiopoulos, Clare L. Scott, Apriliana E. R. Kartikasari and Magdalena Plebanski
Cancers 2025, 17(10), 1691; https://doi.org/10.3390/cancers17101691 
Available online: https://www.mdpi.com/2072-6694/17/10/1691

5. “Insulin-like Growth Factor 1 (IGF1) and Its Isoforms: Insights into the Mechanisms of Endometrial Cancer”
by Abdul Muzhill Hannaan Abdul Hafizz, Norfilza Mohd Mokthar, Reena Rahayu Md Zin, Nigel P. Mongan, Mohd Nazzary Mamat @ Yusof, Nirmala Chandralega Kampan, Kah Teik Chew and Mohamad Nasir Shafiee
Cancers 2025, 17(1), 129; https://doi.org/10.3390/cancers17010129
Available online: https://www.mdpi.com/2072-6694/17/1/129

6. “A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps”
by Ewan Hunter, Heba Alshaker, Cicely Weston, Mutaz Issa, Shekinah Bautista, Abel Gebregzabhar, Anya Virdi, Ann Dring, Ryan Powell, Jayne Green et al.
Cancers 2025, 17(3), 521; https://doi.org/10.3390/cancers17030521
Available online: https://www.mdpi.com/2072-6694/17/3/521

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our Feature Papers from the first half of 2025 in the Section “Cancer Therapy”, which are listed below:

1. “Non-Melanoma Skin Cancer: Assessing the Systemic Burden of the Disease”
   by Emmanouil Karampinis, Dimitra Koumaki, Dimitrios Sgouros, Paraskevi-Maria Nechalioti, Olga Toli, Georgia Pappa, Marios Papadakis, Konstantina-Eirini Georgopoulou, Angeliki-Victoria Schulze-Roussaki and Demetrios Kouretas
   Cancers 2025, 17(4), 703; https://doi.org/10.3390/cancers17040703
   Available online: https://www.mdpi.com/2072-6694/17/4/703
2. “Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy”
   by Elena Chitoran, Vlad Rotaru, Daniela-Cristina Stefan, Giuseppe Gullo and Laurentiu Simion
   Cancers 2025, 17(7), 1126; https://doi.org/10.3390/cancers17071126
   Available online: https://www.mdpi.com/2072-6694/17/7/1126
3. “Prostate Cancer: A Journey Through Its History and Recent Developments”
   by Hamza Mallah, Zania Diabasana, Sina Soultani, Ysia Idoux-Gillet and Thierry Massfelder
   Cancers 2025, 17(2), 194; https://doi.org/10.3390/cancers17020194
   Available online: https://www.mdpi.com/2072-6694/17/2/194
4. “Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities”
   by Aparamita Pandey, Martín Alcaraz, Jr., Pasquale Saggese, Adriana Soto, Estefany Gomez, Shreya Jaldu, Jane Yanagawa and Claudio Scafoglio
   Cancers 2025, 17(3), 466; https://doi.org/10.3390/cancers17030466
   Available online: https://www.mdpi.com/2072-6694/17/3/466
5. “Exploring the Metabolic Impact of FLASH Radiotherapy”
   by Febe Geirnaert, Lisa Kerkhove, Pierre Montay-Gruel, Thierry Gevaert, Inès Dufait and Mark De Ridder
   Cancers 2025, 17(1), 133; https://doi.org/10.3390/cancers17010133
   Available online: https://www.mdpi.com/2072-6694/17/1/133
6. “AI-Driven Enhancement of Skin Cancer Diagnosis: A Two-Stage Voting Ensemble Approach Using Dermoscopic Data”
   by Tsu-Man Chiu, Yun-Chang Li, I-Chun Chi and Ming-Hseng Tseng
   Cancers 2025, 17(1), 137; https://doi.org/10.3390/cancers17010137
   Available online: https://www.mdpi.com/2072-6694/17/1/137

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Drug Development”, which are listed below:

1. “New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment”
by Cristina Amaral, Cristina F. Almeida, Maria João Valente, Carla L. Varela, Saul C. Costa, Fernanda M. F. Roleira, Elisiário Tavares-da-Silva, Anne Marie Vinggaard, Natércia Teixeira and Georgina Correia-da-Silva
Cancers 2025, 17(2), 165; https://doi.org/10.3390/cancers17020165
Available online: https://www.mdpi.com/2072-6694/17/2/165

2. “Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database”
by Razvan Constantin Vonica, Claudiu Morgovan, Anca Butuca, Manuela Pumnea, Remus Calin Cipaian, Adina Frum, Carmen Maximiliana Dobrea, Andreea Loredana Vonica-Tincu, Aliteia-Maria Pacnejer, Florina Batar et al.
Cancers 2025, 17(4), 663; https://doi.org/10.3390/cancers17040663
Available online: https://www.mdpi.com/2072-6694/17/4/663

3. “Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives”
by Sulin Wu and Rajat Thawani
Cancers 2025, 17(5), 801; https://doi.org/10.3390/cancers17050801
Available online: https://www.mdpi.com/2072-6694/17/5/801

4. “ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer”
by Shuqing Zhao, Edward Agyare, Xueyou Zhu, Jose Trevino, Sherise Rogers, Enrique Velazquez-Villarreal, Jason Brant, Payam Eliahoo, Jonathan Barajas, Ba Xuan Hoang et al.
Cancers 2025, 17(5), 870; https://doi.org/10.3390/cancers17050870
Available online: https://www.mdpi.com/2072-6694/17/5/870

5. “Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting”
by Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, Giuliana Salvatore and Maria Letizia Motti
Cancers 2025, 17(8), 1273; https://doi.org/10.3390/cancers17081273
Available online: https://www.mdpi.com/2072-6694/17/8/1273

6. “Camptothein-Based Anti-Cancer Therapies and Strategies to Improve Their Therapeutic Index”
by Jue Gong, Wenqiu Zhang and Joseph P. Balthasar
Cancers 2025, 17(6), 1032; https://doi.org/10.3390/cancers17061032
Available online: https://www.mdpi.com/2072-6694/17/6/1032

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office